Navigate Global Regulatory Submissions with Precision and Strategic Confidence
Master CTD/eCTD dossier preparation, USFDA, EMA, and CDSCO filing strategies, and QA compliance — the skills that make regulatory affairs professionals among the highest-valued in the pharma industry.
Seats are limited per batch. Early registration recommended.
Program Overview
The Executive Masterclass in Drug Regulatory Affairs empowers professionals to navigate the complex web of global pharmaceutical submissions with precision. This program teaches exactly how to draft, structure, and submit regulatory dossiers in CTD and eCTD formats — the international standards used by the FDA, EMA, and every major health authority worldwide.
Regulatory Affairs is one of the most strategic and consistently well-compensated functions in the pharmaceutical sector. Professionals who can prepare and manage global submissions, understand regional filing nuances, and ensure quality compliance are in persistent demand. This program produces them — with the depth, rigour, and real-world orientation the executive tag demands.
Why Global Pharmacovigilance Academy?
You learn the exact structure of Modules 1–5, eCTD backbone logic, versioning, and sequence management — not just what they are, but how to build them.
USFDA, EMA, and CDSCO are covered in dedicated modules. You develop genuine strategic competency across the world's three most important pharmaceutical markets.
Regulatory knowledge without quality discipline is incomplete. Document control, CAPA, and inspection readiness are embedded throughout the curriculum.
You learn both initial submissions and the equally complex post-approval world: variations, label management, and lifecycle strategy.
Is This Program Right for You?
Week-by-Week Curriculum
Each week combines structured knowledge with practical, industry-aligned application.
- RA function in drug development and lifecycle
- Global landscape: ICH, FDA, EMA, CDSCO, WHO
- Submission types: IND, NDA, BLA, MAA, ANDA
- RA career ecosystem: roles, functions, dynamics
- CTD Modules 1–5 structure in detail
- Module 2 summaries: Quality, Non-Clinical, Clinical
- Module 3: Pharmaceutical quality data requirements
- Modules 4 & 5: Pre-clinical and clinical reports
- eCTD specification: ICH M8 and adaptations
- Backbone, lifecycle management, versioning
- Publishing tools: DocuBridge, Lorenz, Veeva basics
- Technical validation and rejection prevention
- IND applications: structure and FDA review
- NDA 505(b)(1), 505(b)(2), ANDA pathways
- FDA meeting requests and pre-submission strategy
- Complete Response Letters and resubmission
- MAA centralised procedure via EMA
- Decentralised, mutual recognition, national procedures
- EMA scientific advice and protocol assistance
- Post-marketing PASS/PAES obligations
- Indian regulatory framework: D&C Act, NDC
- Form 44 (NDA) and Form CT-21 for clinical trials
- BA/BE study requirements for India
- Schedule Y amendments and PV integration
- Drug substance and drug product quality data
- Stability data: ICH Q1A–Q1F guidelines applied
- Specifications, analytical methods, validation
- Manufacturing site GMP and post-approval changes
- Non-clinical overview and tabulated summaries
- Clinical overview and benefit-risk framing
- Integrated summaries of safety (ISS) and efficacy (ISE)
- Orphan drug designations and accelerated pathways
- GMP, GCP, GLP quality system integration
- Document control and version management in RA
- Submission QC checklists and review processes
- Inspection preparation and response strategy
- EU Type IA/IB/II and FDA CBE/PAS variations
- Label management: SmPC, PIL, USPI updates
- Lifecycle management strategy for mature products
- Generic and biosimilar regulatory pathways
- Submission timelines and project planning
- Cross-functional coordination: RA, clinical, QA, PV
- RIMS (Regulatory Information Management Systems)
- Risk management in regulatory delivery
- RA career tracks: submission, CMC, labelling, strategy
- Senior roles: Global RA Manager, VP Regulatory Affairs
- Resume and portfolio building for RA roles
- Interview mastery: submission scenarios
What You Will Be Able to Do
By the end of this program, you will:
What Roles Can You Target After This Program?
Mid-Level Roles
- RA Specialist
- RA Project Manager
- Regional Submissions Lead
- CMC Regulatory Manager
- Regulatory Intelligence Analyst
Entry-Level Roles
- Regulatory Affairs Associate
- Submissions Coordinator
- CMC Documentation Analyst
- Labelling Associate
- Regulatory Operations Executive
Senior / Strategic Roles
- Global Regulatory Manager
- VP Regulatory Affairs
- RA Strategy Director
- Regulatory Consultant (MNC)
- CDSCO / EMA Liaison Specialist
Frequently Asked Questions
Regulatory affairs is one of the highest-demand, highest-compensation functions in pharma globally. With India being one of the world's largest generic drug exporters, RA professionals with USFDA, EMA, and CDSCO expertise are in acute shortage and consistently command premium packages.
A pharmacy, life sciences, or chemistry background is preferred. M.Pharm, B.Pharm, M.Sc. graduates are the primary audience. Professionals from QA, clinical research, or PV backgrounds transitioning into RA are also well-suited.
The Common Technical Document (CTD) is the universal format required by FDA, EMA, CDSCO, and most health authorities for drug approval applications. eCTD is its electronic submission form. If you cannot navigate CTD/eCTD, you cannot work in regulatory submissions — it is as fundamental as MedDRA is to pharmacovigilance.
Yes. Week 6 is dedicated entirely to CDSCO submissions — Form 44, CT-21, BA/BE requirements, and Schedule Y. This makes the program uniquely valuable for professionals targeting Indian pharma companies and CDSCO-regulated operations.
Most participants are interview-ready within 2–4 weeks of completion. Week 12 covers resume building and interview preparation. The practical, workflow-based training throughout the program means you are not starting from zero when you reach employers.
Absolutely — this program is equally designed for working professionals looking to move into RA from QA, clinical, PV, or manufacturing backgrounds. The self-paced structure is designed to be completed alongside full-time employment.
Enroll in Executive Masterclass in Drug Regulatory Affairs (DRA)
Limited seats per batch. Industry-led. Certification upon completion.
admissions@globalpva-edu.com
globalpva-edu.com
Domestic Students (India)
₹39,999
International Students
$1,499
*Fees include examination & certification charges.